|
Dec 9
|
The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable
|
|
Dec 7
|
Theravance Bio (TBPH) Up 2.5% Since Last Earnings Report: Can It Continue?
|
|
Aug 9
|
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q2 2023 Earnings Call Transcript
|
|
Aug 8
|
Theravance's (TBPH) Q2 Earnings Beat Estimates, Revenues Miss
|
|
Aug 7
|
Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 7
|
Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
|